PYC Therapeutics Limited (ASX:PYC)
Australia · Delayed Price · Currency is AUD 2.250
-0.010 (-0.44%)
Aug 28, 2026, 4:10 PM AEST
PYC Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 53.56 | 153.05 | 66.87 | 15.57 | 29.11 |
Short-Term Investments | 394 | - | - | - | - |
Cash & Short-Term Investments | 447.56 | 153.05 | 66.87 | 15.57 | 29.11 |
Cash Growth | 192.43% | 128.86% | 329.47% | -46.51% | -43.48% |
Accounts Receivable | 34.13 | - | - | - | - |
Other Receivables | - | 24.07 | 18 | 16.25 | 10.07 |
Receivables | 34.13 | 24.07 | 18 | 16.25 | 10.07 |
Other Current Assets | 0.55 | 0.41 | 0.74 | 0.05 | 0.07 |
Total Current Assets | 482.23 | 177.53 | 85.61 | 31.87 | 39.25 |
Property, Plant & Equipment | 1.43 | 1.9 | 1.57 | 1.04 | 1.63 |
Long-Term Investments | 221.2 | - | - | - | - |
Other Intangible Assets | 3.65 | 3.85 | 4.05 | 4.25 | 4.45 |
Other Long-Term Assets | - | - | - | - | 0.02 |
Total Assets | 708.52 | 183.28 | 91.24 | 37.17 | 45.35 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 13.15 | 8.75 | 7.53 | 4.92 | 2.57 |
Accrued Expenses | 0.9 | 2.65 | 1.26 | 3.15 | 1.38 |
Current Portion of Leases | 0.36 | 0.4 | 0.31 | 0.18 | 0.26 |
Other Current Liabilities | - | 0.52 | 0.01 | 0.15 | 0.17 |
Total Current Liabilities | 14.4 | 12.32 | 9.11 | 8.41 | 4.39 |
Long-Term Leases | 0.27 | 0.62 | 0.8 | 0.14 | 0.68 |
Pension & Post-Retirement Benefits | 0.51 | 0.33 | 0.27 | 0.18 | 0.08 |
Total Liabilities | 15.18 | 13.27 | 10.18 | 8.72 | 5.15 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 933.25 | 369.59 | 230.58 | 140.09 | 125.99 |
Retained Earnings | -249.54 | -206.2 | -155.89 | -118.17 | -95.38 |
Comprehensive Income & Other | 9.62 | 6.18 | 5.81 | 5.83 | 8.74 |
Total Common Equity | 693.33 | 169.57 | 80.5 | 27.75 | 39.35 |
Minority Interest | 0.01 | 0.43 | 0.56 | 0.69 | 0.85 |
Shareholders' Equity | 693.34 | 170.01 | 81.05 | 28.44 | 40.2 |
Total Liabilities & Equity | 708.52 | 183.28 | 91.24 | 37.17 | 45.35 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.62 | 1.02 | 1.11 | 0.32 | 0.94 |
Net Cash (Debt) | 446.94 | 152.03 | 65.76 | 15.26 | 28.17 |
Net Cash Growth | 193.99% | 131.18% | 331.05% | -45.84% | -44.52% |
Net Cash Per Share | 0.61 | 0.30 | 0.17 | 0.05 | 0.09 |
Filing Date Shares Outstanding | 882.87 | 583.26 | 466.61 | 373.29 | 318.09 |
Total Common Shares Outstanding | 882.87 | 583.26 | 466.61 | 341.65 | 318.09 |
Working Capital | 467.83 | 165.21 | 76.51 | 23.47 | 34.86 |
Book Value Per Share | 0.79 | 0.29 | 0.17 | 0.08 | 0.12 |
Tangible Book Value | 689.68 | 165.72 | 76.45 | 23.5 | 34.9 |
Tangible Book Value Per Share | 0.78 | 0.28 | 0.16 | 0.07 | 0.11 |
Machinery | - | 4.53 | 3.55 | 3.24 | 2.81 |